Wilms’ Tumor 1 Gene Mutations Independently Predict Poor Outcome in Adults With Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study
Peter Paschka(European Bioinformatics Institute), Clara D. Bloomfield(North Shore University Hospital), Claudia D. Baldus(University Hospital Schleswig-Holstein), Michael A. Caligiuri(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Maria R. Baer(University of Maryland, Baltimore), Guido Marcucci(City of Hope), Jonathan E. Kolitz(Memorial Sloan Kettering Cancer Center), Richard A. Larson(Urbana University), Andrew J. Carroll(University of Alabama at Birmingham), Krzysztof Mrózek(The Ohio State University), Weiqiang Zhao(Harbin Institute of Technology), Bayard L. Powell(Atrium Health Wake Forest Baptist), Amy S. Ruppert(The University of Texas MD Anderson Cancer Center), Christian Langer(University Hospital Ulm), Susan P. Whitman(The Ohio State University Wexner Medical Center), Kati Maharry(Peter MacCallum Cancer Centre)
Cited by 258
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k